Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 3Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Rectal Neoplasms 4Colorectal Neoplasms 4Sarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Astrocytoma 2Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Carcinoma In Situ 1Brain Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 170130-nm albumin-bound paclitaxel 54Albumin-Bound Paclitaxel 42Oxaliplatin 33Fluorouracil 32pembrolizumab 30Capecitabine 30Leucovorin 28Irinotecan 28Radiotherapy 25Nivolumab 22Erlotinib Hydrochloride 21Taxes 19Cisplatin 19Bevacizumab 15Magnetic Resonance Spectroscopy 13Specimen Handling 12Radiosurgery 11Ipilimumab 11Cyclophosphamide 11Drug Therapy 10Carboplatin 10Biopsy 10Paclitaxel 9Docetaxel 9Cetuximab 9trametinib 8olaparib 8durvalumab 8Sorafenib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pancreatic Neoplasms × Neoadjuvant Therapy × Clear all
NCT01192763 2013-09-30

RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡